Reference : The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a ...
Scientific journals : Article
Human health sciences : Dermatology
The beneficial toxicity paradox of antimicrobials in leg ulcer healing impaired by a polymicrobial flora: a proof-of-concept study.
Fumal, I. [Centre Hospitalier régional de Huy > > > > Dermatologie > >]
Braham, C. [Centre Hospitalier Régional de Huy > > > > Dermatologie > >]
Paquet, Philippe mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Pierard, Claudine [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Pierard, Gérald mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Dermatology : International Journal for Clinical & Investigative Dermatology
S. Karger
204 Suppl 1
Yes (verified by ORBi)
[en] Anti-Infective Agents, Local/adverse effects/therapeutic use ; Chlorhexidine/adverse effects/analogs & derivatives/therapeutic use ; Humans ; Leg Ulcer/drug therapy/microbiology ; Middle Aged ; Povidone-Iodine/adverse effects/therapeutic use ; Silver Sulfadiazine/adverse effects/therapeutic use ; Wound Healing/drug effects
[en] BACKGROUND: Some of the views contrasting the beneficial and toxic effects of antimicrobials upon wound healing remain controversial. OBJECTIVE: To assess the clinical relevance of histological findings following antimicrobial applications on chronic leg ulcers. METHOD: The present study was performed in three parallel groups of 17 patients suffering from at least 2 similar chronic leg ulcers. Clinical planimetric assessments were performed before and after 3 and 6 weeks of treatment using hydrocolloid dressings. In addition, 1 ulcer in each patient received applications of povidone-iodine (PVP-I), silver sulfadiazine or chlorhexidine digluconate. Histological examinations were made at inclusion and after the 6-week therapy. Time to healing was also recorded. RESULTS: At entry in the study, fibroblasts, macrophages, neutrophils and vessels were abundant in the ulcers. In addition, focal necrotizing vasculitis was related to the microbiological load. Compared to the control lesions, both the healing rate and time to healing of the leg ulcers showed a modest improvement at the sites receiving silver sulfadiazine (2-7%) or chlorhexidine digluconate (-1 to 5%). By contrast, PVP-I increased significantly the healing rate (4-18%, p < 0.01), and time to healing was reduced by 2-9 weeks (p < 0.01). The 3 antimicrobials decreased the bacterial density, and the vascular margination and migration of inflammatory cells, thus abating the vasculitic changes. PVP-I applications did not alter the microvessels and did not significantly reduce the density in dendrocytes and fibroblasts. By contrast, both silver sulfadiazine and chorhexidine digluconate appeared to alter the superficial microsvasculature including the dendrocyte population. CONCLUSION: Although topical antimicrobials may apparently achieve almost similar activity on the bacterial load inside chronic leg ulcers, the toxicity upon host cells was different among these agents. PVP-I appeared to be an efficient compound in these respects exhibiting a positive and relevant clinical effect.
Copyright 2002 S. Karger AG, Basel

File(s) associated to this reference

Fulltext file(s):

Restricted access
BENEFICIAL*.pdfAuthor postprint136 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.